Cargando…

High Expression of DEPDC1 Promotes Malignant Phenotypes of Breast Cancer Cells and Predicts Poor Prognosis in Patients With Breast Cancer

DEP domain containing 1 (DEPDC1) is a novel tumor-associated gene, which is aberrantly expressed in multiple types of cancer and involves in tumorigenesis and cancer progression. Here, we examined the functional involvement and underlying mechanism of DEPDC1 in breast cancer. In this study, the immu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Huishan, Yu, Mingwei, Sui, Laijian, Gong, Benjiao, Zhou, Bo, Chen, Jian, Gong, Zhaohua, Hao, Cuifang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473048/ https://www.ncbi.nlm.nih.gov/pubmed/31032225 http://dx.doi.org/10.3389/fonc.2019.00262

Ejemplares similares

Aberrant expression of bone morphogenetic proteins in the disease progression and metastasis of breast cancer
por: Liu, Ming, et al.
Publicado: (2023)

Exploring the Pharmacological Mechanism of the Herb Pair “HuangLian-GanJiang” against Colorectal Cancer Based on Network Pharmacology
por: Gong, Benjiao, et al.
Publicado: (2019)

DEPDC1B promotes development of cholangiocarcinoma through enhancing the stability of CDK1 and regulating malignant phenotypes
por: Zhang, Zhenhai, et al.
Publicado: (2022)

Identification of Hub Genes Related to Carcinogenesis and Prognosis in Colorectal Cancer Based on Integrated Bioinformatics
por: Gong, Benjiao, et al.
Publicado: (2020)

Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis
por: Chen, Gang, et al.
Publicado: (2021)

A network pharmacology approach to explore active compounds and pharmacological mechanisms of epimedium for treatment of premature ovarian insufficiency
por: Zhao, Huishan, et al.
Publicado: (2019)

High Expression of DEPDC1B Predicts Poor Prognosis in Lung Adenocarcinoma
por: Li, Pulin, et al.
Publicado: (2022)

Low Expression of the Polycomb Protein RING1 Predicts Poor Prognosis in Human Breast Cancer
por: Gao, Song, et al.
Publicado: (2021)

Low CRIM1 Levels Predict Poor Prognosis in Breast Cancer Patients
por: Wen, Wei, et al.
Publicado: (2022)

Editorial: Transcription Factors Drivers of Malignancy, Progression and Poor Outcomes in Breast Cancer
por: Parisi, Eva, et al.
Publicado: (2022)

The Prognosis of Single Hormone Receptor-Positive Breast Cancer Stratified by HER2 Status
por: Zhao, Hengqiang, et al.
Publicado: (2021)

Expression of Monocarboxylate Transporter 1 in Immunosuppressive Macrophages Is Associated With the Poor Prognosis in Breast Cancer
por: Li, Bei, et al.
Publicado: (2020)

FOXM1 is regulated by DEPDC1 to facilitate development and metastasis of oral squamous cell carcinoma
por: Qiu, Jing, et al.
Publicado: (2022)

Localization of GPSM2 in the Nucleus of Invasive Breast Cancer Cells Indicates a Poor Prognosis
por: Deng, Mingming, et al.
Publicado: (2020)

Overexpression of Long Non-Coding RNA Linc01315 Predicts Poor Prognosis in Breast Cancer
por: Xue, Jingyan, et al.
Publicado: (2021)

Long Non-Coding RNA LINC00467 Correlates to Poor Prognosis and Aggressiveness of Breast Cancer
por: Zhang, Ying, et al.
Publicado: (2021)

Comprehensive analysis of the expression and prognosis for RAI2: A promising biomarker in breast cancer
por: Jiao, Ying, et al.
Publicado: (2023)

AB079. Upregulation of DEPDC1B correlates with tumor progression and predicts a poor prognosis in prostate cancer
por: Cui, Feilun, et al.
Publicado: (2017)

Low expression of HIF1AN accompanied by less immune infiltration is associated with poor prognosis in breast cancer
por: Tang, Shasha, et al.
Publicado: (2023)

Deregulated molecules and pathways in the predisposition and dissemination of breast cancer cells to bone
por: Sui, Laijian, et al.
Publicado: (2022)

Editorial: Impact of Breast MRI on Breast Cancer Treatment and Prognosis
por: Bitencourt, Almir, et al.
Publicado: (2022)

Origanum syriacum L. Attenuates the Malignant Phenotype of MDA-MB231 Breast Cancer Cells
por: AlKahlout, Amal, et al.
Publicado: (2022)

UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb
por: Guo, Yanjing, et al.
Publicado: (2023)

Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer
por: Sanomachi, Tomomi, et al.
Publicado: (2023)

Overexpression of EZH2/NSD2 Histone Methyltransferase Axis Predicts Poor Prognosis and Accelerates Tumor Progression in Triple-Negative Breast Cancer
por: Gao, Bo, et al.
Publicado: (2021)

Osteoprotegerin: Relationship to Breast Cancer Risk and Prognosis
por: Geerts, Dirk, et al.
Publicado: (2020)

High Expression of Complement Component C7 Indicates Poor Prognosis of Breast Cancer and Is Insensitive to Taxane-Anthracycline Chemotherapy
por: Zhang, Huikun, et al.
Publicado: (2021)

Mutant p53 and Twist1 Co-Expression Predicts Poor Prognosis and Is an Independent Prognostic Factor in Breast Cancer
por: Zhang, Yong-Qu, et al.
Publicado: (2021)

circUSP42 Is Downregulated in Triple-Negative Breast Cancer and Associated With Poor Prognosis
por: Yu, Jinling, et al.
Publicado: (2020)

Effect of adjuvant radiotherapy after breast-conserving surgery in elder women with early-stage breast cancer: a propensity-score matching analysis
por: Han, Tingting, et al.
Publicado: (2023)

Poor health literacy associated with stronger perceived barriers to breast cancer screening and overestimated breast cancer risk
por: Poon, Paul K. M., et al.
Publicado: (2023)

CYC1 Predicts Poor Prognosis in Patients with Breast Cancer
por: Han, Yingyan, et al.
Publicado: (2016)

Systematic Investigation of Scutellariae Barbatae Herba for Treating Hepatocellular Carcinoma Based on Network Pharmacology
por: Gong, Benjiao, et al.
Publicado: (2018)

High Moesin Expression Is a Predictor of Poor Prognosis of Breast Cancer: Evidence From a Systematic Review With Meta-Analysis
por: Hu, Xiaoli, et al.
Publicado: (2021)

Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer
por: Li, Huihui, et al.
Publicado: (2023)

HPV DNA Associates With Breast Cancer Malignancy and It Is Transferred to Breast Cancer Stromal Cells by Extracellular Vesicles
por: De Carolis, Sabrina, et al.
Publicado: (2019)

Effect of Pyroptosis-Related Genes on the Prognosis of Breast Cancer
por: Zhou, Ying, et al.
Publicado: (2022)

Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells
por: Yousefnia, Saghar, et al.
Publicado: (2020)

A novel risk score model based on gamma-aminobutyric acid signature predicts the survival prognosis of patients with breast cancer
por: Yang, Liping, et al.
Publicado: (2023)

Vitamin D Deficiency is Correlated with Poor Outcomes in Patients with Luminal-type Breast Cancer
por: Kim, Hee Jeong, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9j4kg2339doauivia7dd9c7b6v